Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
CPRX, ZVRA, TBPH, ALDX, and LRMR shine amid tariff threats, thanks to strong pipelines, demand, and rising earnings estimates.
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
Innovation is at its peak in the Zacks Medical-Drugs industry. CPRX, ZVRA, TBPH, ALDX and LRMR may prove to be good additions to one's portfolio.
Aldeyra Therapeutics ( ALDX ) Upgraded to Strong Buy: What Does It Mean for the Stock?
Aldeyra Therapeutics (ALDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Are Medical Stocks Lagging Amgen ( AMGN ) This Year?
Here is how Amgen (AMGN) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon ( NYSE:ALC )
Up to 4x more patients on Tryptyr had a ≥10mm tear increase vs. placebo at Day 14 in COMET-2 and COMET-3 ( p<0.0001 ) . Tryptyr showed statistically significant tear production as early as Day 1, with results sustained through Day 90.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, May 18, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm - Aldeyra Therapeutics ( NASDAQ:ALDX ) , ICU Medical ( NASDAQ:ICUI )
NEW YORK, May 14, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organon & Co. OGN, Aldeyra Therapeutics, Inc. ALDX, Landstar System, Inc. LSTR, and ICU Medical, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, May 13, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Robinhood Markets ( NASDAQ:HOOD )
NEW YORK, May 07, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RobinHood Markets, Inc. HOOD, Aldeyra Therapeutics, Inc. ALDX, Landstar System, Inc. LSTR, and ICU Medical, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, May 05, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
ALDX SECURITIES ALERT: Lose Money on Aldeyra Therapeutics, Inc.? Contact BFA Law about Securities Investigation ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, May 05, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX INQUIRY NOTICE: Aldeyra Therapeutics ( NASDAQ:ALDX ) Investors may have been affected by Securities Violations -- Contact BFA Law - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, May 03, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 29, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
ALDX ALERT: Aldeyra Therapeutics ( NASDAQ:ALDX ) Investors are Reminded of Pending Securities Investigation - Contact BFA Law - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 29, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics ( NASDAQ:ALDX ) is being Investigated after 75% Stock Drop - Investors are Urged to Contact BFA Law - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 27, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX SHAREHOLDER ALERT: BFA Law Reminds Aldeyra Therapeutics, Inc. Investors of the Continuing Securities Investigation
New York, New York-- ( Newsfile Corp. - April 26, 2025 ) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ( NASDAQ: ALDX ) for potential violations of the federal securities laws.
ALDX SHAREHOLDERS: Aldeyra Therapeutics, Inc. ( NASDAQ:ALDX ) 75% Stock Drop Triggers Investigation - Contact BFA Law if You Lost Money - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
LEGAL NOTICE: Aldeyra Therapeutics, Inc. ( NASDAQ:ALDX ) Investors are Notified of the Pending Securities Investigation - Contact BFA Law - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX LEGAL REMINDER: Did Aldeyra Therapeutics, Inc. Commit Securities Violations? Contact BFA Law ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 21, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX INVESTORS: Investors that Suffered Losses on Aldeyra Therapeutics, Inc. are Alerted to Contact BFA Law
New York, New York-- ( Newsfile Corp. - April 20, 2025 ) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ( NASDAQ: ALDX ) for potential violations of the federal securities laws.
ALDX INVESTOR NEWS: Aldeyra Therapeutics, Inc. Investors may be able to Recover Losses in Class Action Investigation -- Contact BFA Law ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 19, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
Bragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the Firm - Aldeyra Therapeutics ( NASDAQ:ALDX ) , TechTarget ( NASDAQ:TTGT )
NEW YORK, April 15, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TechTarget, Inc. TTGT and Aldeyra Therapeutics, Inc.
ALDX STOCK REMINDER: The Aldeyra Therapeutics, Inc. Investigation is Ongoing - Investors are Urged to Contact BFA Law ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 13, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Aldeyra Stockholders and Encourages Investors to Contact the Firm - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 10, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX on behalf of Aldeyra stockholders.
Aldeyra Therapeutics, Inc. ( ALDX ) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman - Aldeyra Therapeutics ( NASDAQ:ALDX )
SAN FRANCISCO, April 09, 2025 ( GLOBE NEWSWIRE ) -- On April 3, 2025 investors in Aldeyra Therapeutics, Inc. ( NASDAQ:ALDX ) saw the price of their shares crash over 70% after the company announced that it received a Complete Response Letter ( "CRL" ) from the FDA for the resubmission of the New ...
ALDX SECURITIES REPORT: Aldeyra Therapeutics, Inc. Securities Investigation Could Allow Investors to Recover Losses; Contact BFA Law ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 07, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
ALDX SECURITIES ALERT: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation; Contact BFA Law ( NASDAQ:ALDX ) - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 05, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. ALDX for potential violations of the federal securities laws.
Kirby McInerney LLP Announces Investigation of Possible Claims Against Aldeyra Therapeutics, Inc. ( ALDX ) on Behalf of Investors - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 04, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. The investigation concerns whether Aldeyra and/or certain of its officers have violated the federal ...
INVESTOR ALERT: Investigation of Aldeyra Therapeutics, Inc. ( ALDX ) Announced by Holzer & Holzer, LLC - Aldeyra Therapeutics ( NASDAQ:ALDX )
ATLANTA, April 04, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX complied with federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 03, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Crude Oil Dips 7%; ISM Services PMI Falls In March - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Goodyear Tire & Rubber ( NASDAQ:GT )
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 800 points on Thursday. The Dow traded down 3.07% to 40,929.87 while the NASDAQ fell 4.83% to 16,750.33. The S&P 500 also fell, dropping, 3.73% to 5,459.39. Consumer staples shares rose by 0.4% on Thursday.
BREAKING: Block & Leviton Investigating Aldeyra Therapeutics ( ALDX ) For Securities Fraud After Shares Fall Nearly 75%; Investors Encouraged to Contact the Firm - Aldeyra Therapeutics ( NASDAQ:ALDX )
BOSTON, April 03, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Aldeyra Therapeutics, Inc. ALDX for potential securities law violations. Investors who have lost money in their Aldeyra Therapeutics, Inc. investment should contact the firm to learn more about how they might recover ...
Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall - American Rebel Holdings ( NASDAQ:AREB ) , Aldeyra Therapeutics ( NASDAQ:ALDX )
U.S. stocks traded lower this morning, with the Nasdaq Composite dipping more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 2.64% to 41,110.44 while the NASDAQ fell 4.15% to 16,870.74. The S&P 500 also fell, dropping, 3.14% to 5,492.92.
FDA Rejects Aldeyra's Reproxalap For Dry Eye Disease Again, Citing Efficacy Concerns - Aldeyra Therapeutics ( NASDAQ:ALDX )
Aldeyra expects to announce topline results from ongoing trials in Q2 2025. The company reported $101 million in cash and marketable securities as of Dec. 31, 2024. The 'Trade of the Day' is now live. Get a high-probability setup with clear entry and exit points right here. The U.S.
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Amplitude ( NASDAQ:AMPL )
SAN DIEGO, Dec. 26, 2024 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Aldeyra Therapeutics, Inc. ALDX, UnitedHealth Group Incorporated UNH, Blue Ridge Bankshares, Inc.
Is the Options Market Predicting a Spike in Aldeyra Therapeutics ( ALDX ) Stock?
Investors need to pay close attention to Aldeyra Therapeutics (ALDX) stock based on the movements in the options market lately.
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
The FDA accepts Aldeyra's resubmitted NDA for topical ocular reproxalap to treat the signs and symptoms of dry eye disease. Stock rises.
Is BellRing Brands ( BRBR ) Outperforming Other Medical Stocks This Year?
Here is how BellRing Brands (BRBR) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
Dr. Gary M. Phillips brings over three decades of experience in the pharmaceutical and healthcare industries to BioConnection. Since May 2022, he has served as Chief Business Officer of Anaveon AG. He was President & CEO of OrphoMed from 2018 to 2022.
Aldeyra's New Eye Drug Shows Positive Results In FDA-Approved Study, Stock Jumps Over 30% - Aldeyra Therapeutics ( NASDAQ:ALDX )
Aldeyra Therapeutics Inc.'s ALDX Phase 3 dry eye chamber clinical trial of 0.25% reproxalap ophthalmic solution achieves the primary endpoint.
Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The molecular glues pipeline and clinical trial analysis report delivers important insights on ongoing research, clinical strategies, upcoming therapeutics, and commercial analysis.
Investigation Alert: Aldeyra, Eagle Pharmaceuticals, and Blue Ridge Bankshares: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Blue Ridge Bankshares ( AMEX:BRBS )
SAN DIEGO, June 13, 2024 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Aldeyra Therapeutics, Inc. ALDX, Eagle Pharmaceuticals, Inc. EGRX, and Blue Ridge Bankshares, Inc.
Aldeyra Therapeutics ( NASDAQ:ALDX ) Downgraded to Sell at StockNews.com
StockNews.com lowered shares of Aldeyra Therapeutics ( NASDAQ:ALDX - Free Report ) from a hold rating to a sell rating in a report published on Wednesday. Other equities research analysts have also issued research reports about the stock.
Is Aldeyra Therapeutics ( ALDX ) Stock Outpacing Its Medical Peers This Year?
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Teva Pharmaceutical Industries Ltd. (TEVA) have performed compared to their sector so far this year.
Aldeyra Therapeutics ( NASDAQ:ALDX ) Stock Rating Lowered by StockNews.com
Aldeyra Therapeutics ( NASDAQ:ALDX - Get Free Report ) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Monday.
Is Aldeyra Therapeutics ( ALDX ) Outperforming Other Medical Stocks This Year?
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.
Aldeyra ( ALDX ) Stock Rallies 43% in One Week: Here's Why
Aldeyra (ALDX) rises 43% in one week, driven by plans to initiate a pivotal study to support the resubmission of reproxalap NDA for dry eye disease in the first half of 2024.
Are Medical Stocks Lagging Aclaris Therapeutics ( ACRS ) This Year?
Here is how Aclaris Therapeutics (ACRS) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Alzamend Neuro ( NASDAQ:ALZN )
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
